Free Trial
ASX:CPH

Creso Pharma (CPH) Stock Price, News & Analysis

Creso Pharma logo

About Creso Pharma Stock (ASX:CPH)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Receive CPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creso Pharma and its competitors with MarketBeat's FREE daily newsletter.

CPH Stock News Headlines

Cipher Pharmaceuticals Announces Q3 2024 Financial Results
Democrats Sold Out the American Dream - Are you ready?
There's a massive housing crisis looming, and nobody on Main Street knows it yet... The Democrats sold out the American Dream - and now, millions of Americans are locked out of the housing market, forced to become "permanent renters."
See More Headlines

CPH Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Creso Pharma investors own include Evolution Mining (EVN), Skin Elements (SKN), Santos (STO), Aurizon (AZJ), C29 Metals (C29), CIMIC Group (CIM) and CSL (CSL).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-32,780,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.92 million
Book Value
A$0.01 per share

Miscellaneous

Outstanding Shares
2,570,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
2.62
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (ASX:CPH) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners